slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 44,761-44,790
Pages 2,019
Rows per page 30
Component
44,761-44,790 of 60,568
18
Freightos | Results Presentation Deck | 23 slidesFreightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations Beat · Action1 hit
22
Freightos | Results Presentation Deck | 23 slidesFreightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations 1 hit
23
The table includes adjustments for share-based compensation, depreciation, listing expenses, and other non-recurring items.Freightos | Results Presentation Deck | 23 slides · Freightos
Conference presentation Investor relations 1 hit
08
Freyr | Results Presentation Deck | 13 slidesFreyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide presents a comparative financial table for Q4 and full-year 2022 vs 2023.Freyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a waterfall chart to explain the change in cash position.Freyr | Results Presentation Deck | 13 slides · FREYR
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to show clinical trial progress across different indications and routes of administration.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
11
Data presented in a table format comparing patient cohorts against clinical metrics.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
15
The slide uses a bar chart to compare efficacy metrics (RECIST1.1, CA-125, PFS-6-month) across various clinical studies, with Genelux's VIRO-15 trial highlighted.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
16
The slide outlines a clinical trial protocol, specifically a randomized open-label study comparing an experimental arm to an active comparator arm.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
20
Genelux | Investor Presentation Deck | 37 slidesGenelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
21
The slide highlights the synergy between two existing therapies (TVI and Olvi-Vec) to create a new modality.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
27
Includes specific footnotes regarding market close date, cash reporting date, and PIPE commitment details.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations 1 hit
03
Includes a table of net sales by product, a pie chart of sales mix, and bulleted financial highlights.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
09
Includes a footnote regarding selling days and the Kamco transaction.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
10
Includes footnotes regarding selling days, Kamco transaction, and reconciliation of non-GAAP metrics.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
12
Includes operational metrics like business days and branch counts alongside standard income statement line items.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
13
Includes supplemental disclosures and a reconciliation for free cash flow.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
14
The table includes two distinct sections: one by growth driver (Organic, Acquisitions, Fx Impact) and one by product segment (Wallboard, Ceilings, Steel Framing, Complementary Products).GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
15
Includes detailed adjustments (A-H) with corresponding commentary.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
16
The table covers 2017 through 3Q24 LTM.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
17
The slide provides a standard financial reconciliation for non-GAAP measures.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
18
Includes a commentary section explaining specific adjustment categories (A-E).GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
19
Includes footnotes detailing unamortized discounts and deferred financing costs.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
20
Includes a note regarding selling days and the exclusion of the Kamco transaction.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations 1 hit
22
The slide presents a side-by-side comparison of IFRS and Non-IFRS metrics, highlighting revenue, margins, and profitability.Gogoro | Investor Presentation Deck | 29 slides · Gogoro
Pitch deck Investor relations Beat · Financials1 hit
27
The slide provides a detailed breakdown of IFRS revenue vs. constant currency (revenue excluding FX effect) for hardware sales and battery swapping services.Gogoro | Investor Presentation Deck | 29 slides · Gogoro
Pitch deck Investor relations 1 hit
29
The table provides a bridge between GAAP/IFRS net loss and non-IFRS adjusted EBITDA by adding back interest, taxes, depreciation, amortization, and various non-recurring or non-cash items.Gogoro | Investor Presentation Deck | 29 slides · Gogoro
Pitch deck Investor relations 1 hit
33
Includes financial projections for revenue, growth, and EBITDA, plus four strategic drivers.Hims & Hers | Investor Presentation Deck | 41 slides · Hims & Hers
Pitch deck Investor relations Beat · Financials1 hit
37
Includes adjustments for stock-based compensation, D&A, acquisition costs, and other non-recurring items.Hims & Hers | Investor Presentation Deck | 41 slides · Hims & Hers
Pitch deck Investor relations 1 hit